← Back to guidelines
Urology7 papers

Pyonephrosis

Last edited: 4/14/2026

Overview

Pyonephrosis is a severe condition characterized by suppurative infection within the renal pelvis and calyces, often secondary to urinary obstruction, typically by stones, leading to abscess formation and potential systemic complications 136.

Diagnosis

  • Key Diagnostic Criteria: Presence of fever, flank pain, palpable mass, and signs of systemic infection 13.
  • Recommended Tests:
  • - Abdominal radiographs may show fragmented staghorn calculi as a suggestive sign 1. - Ultrasound or CT scan to visualize abscess formation, hydronephrosis, and calculi 13. - Urinalysis often reveals pyuria and bacteriuria 36.
  • Grading: Not explicitly detailed in abstracts, but severity often correlates with imaging findings and clinical presentation 13.
  • Management

  • First-Line Treatments:
  • - Surgical Intervention: Nephrectomy is commonly performed, especially in severe cases (62% of cases) 4. - Drainage Procedures: Nephrostomy or other drainage methods used in cases where conservative surgery is considered 4.
  • Adjunctive Treatments:
  • - Antibiotics: Long-term antibiotic therapy, though efficacy varies; specific drug classes and doses not detailed 6. - Stone Removal: Obstructing stones may need removal to alleviate obstruction 4.

    Special Populations

  • Comorbidities: Septic thrombosis of renal vein and vena cava can complicate management, mimicking renal carcinoma 3.
  • Postoperative Considerations: Benign cholestatic jaundice may occur post-nephrectomy in patients with pyonephrosis and sepsis 5.
  • Key Recommendations

  • Surgical intervention, particularly nephrectomy, is often necessary for severe pyonephrosis (Evidence: Strong 4).
  • Imaging, including abdominal radiographs and CT scans, should guide diagnosis and management (Evidence: Moderate 13).
  • Consider nephrostomy or other drainage procedures when conservative surgery is feasible (Evidence: Moderate 4).
  • Long-term antibiotic therapy may be required but efficacy varies; individualized treatment based on culture results is advised (Evidence: Weak 6).
  • Monitor for postoperative complications such as cholestatic jaundice in patients undergoing nephrectomy for pyonephrosis (Evidence: Expert opinion 5).
  • References

    1 Penter G, Arkell DG. The fragmented staghorn calculus: a radiological sign of pyonephrosis. Clinical radiology 1989. link80027-3) 2 Mooreville M, Elkouss GC, Schuster A, Pearce AE, Rosen J. Spontaneous renocolic fistula secondary to calculous pyonephrosis. Urology 1988. link90042-8) 3 Eijsten A, Leisinger HJ, Jucker A. Unilateral pyonephrosis with septic thrombosis of the renal vein and vena cava. Urologia internationalis 1986. link 4 Harrison GS. The management of pyonephrosis. Annals of the Royal College of Surgeons of England 1983. link 5 Mukamel E, Douer D, Pinkhas J, Servadio C. Benign cholestatic jaundice after nephrectomy for pyonephrosis and sepsis. The Journal of urology 1979. link56842-1) 6 Altmann G, Melzer M. Pyonephrosis due to salmonella cholerae-suis variant kunzendorf. Infection 1975. link

    Original source

    1. [1]
      The fragmented staghorn calculus: a radiological sign of pyonephrosis.Penter G, Arkell DG Clinical radiology (1989)
    2. [2]
      Spontaneous renocolic fistula secondary to calculous pyonephrosis.Mooreville M, Elkouss GC, Schuster A, Pearce AE, Rosen J Urology (1988)
    3. [3]
      Unilateral pyonephrosis with septic thrombosis of the renal vein and vena cava.Eijsten A, Leisinger HJ, Jucker A Urologia internationalis (1986)
    4. [4]
      The management of pyonephrosis.Harrison GS Annals of the Royal College of Surgeons of England (1983)
    5. [5]
      Benign cholestatic jaundice after nephrectomy for pyonephrosis and sepsis.Mukamel E, Douer D, Pinkhas J, Servadio C The Journal of urology (1979)
    6. [6]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG